SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-18-020177
Filing Date
2018-11-09
Accepted
2018-11-09 08:02:01
Documents
49
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q plxp20180930_10q.htm 10-Q 531543
2 EXHIBIT 10.1 ex_127181.htm EX-10.1 180600
3 EXHIBIT 31.1 ex_126584.htm EX-31.1 14913
4 EXHIBIT 31.2 ex_126585.htm EX-31.2 15465
5 EXHIBIT 32.1 ex_126586.htm EX-32.1 10376
12 plxp20180930_10qimg001.jpg GRAPHIC 2964
  Complete submission text file 0001437749-18-020177.txt   3459045

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT plxp-20180930.xml EX-101.INS 482138
7 XBRL TAXONOMY EXTENSION SCHEMA plxp-20180930.xsd EX-101.SCH 40607
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plxp-20180930_cal.xml EX-101.CAL 39998
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plxp-20180930_def.xml EX-101.DEF 292121
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE plxp-20180930_lab.xml EX-101.LAB 286820
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plxp-20180930_pre.xml EX-101.PRE 305512
Mailing Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054
Business Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054 (713) 842-1249
PLx Pharma Inc. (Filer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36351 | Film No.: 181171425
SIC: 2834 Pharmaceutical Preparations